QUATTRO IN ACTION
DERMATOLOGY + PLASTIC SURGERY
What country-specific product and pricing strategies can improve the outlook for vital international growth?
INTERNATIONAL LEADERSHIP TEAM OF TOP AESTHETIC MANUFACTURER
A US medical products maker had developed one of the world’s leading technologies for noninvasive body and facial aesthetic procedures.
Capital and consumable sales were strong in the US. However, in many important international markets, the growth outlook was unclear due to increasing availability of low-end lookalike products that offered reduced procedure price but dubious efficacy.
The senior team wanted to understand its realistic potential over the next several years along with key drivers and barriers in vital countries in EMEA, APAC, and Latin America.
Quattro conducted primary physicians research in local languages as well as English with hundreds of clinicians throughout top priority countries around the world, including Germany, France, UK, Italy, Spain, Russia, Brazil, Japan, China, South Korea, Taiwan, Australia, New Zealand, and more.
Developed a systematic growth assessment and action plan for each major country market throughout EMEA, APAC, and Latin America.
Quattro used primary physician and competitor research to create an overall growth assessment and country strategy for each geographic market.
Quattro used reactions to the company’s systems as well as to competitors’ products to systematically clarify company strengths, weaknesses, and top action implications within each country and global region.